Results 31 to 40 of about 336,645 (152)

Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited

open access: yes, 2022
SIMPLE SUMMARY: Multimodal treatment of rectal cancer is undergoing dynamic change. In phase II/III multimodal rectal cancer trials, long-term survival remains the most objective endpoint for reporting treatment efficacy, but long follow-up is required ...
Diefenhardt, Markus   +23 more
core   +1 more source

Laparoscopic low anterior resection for rectal cancer with rectal prolapse: a case report

open access: yesJournal of Medical Case Reports, 2018
Background Rectal cancer with rectal prolapse is rare, described by only a few case reports. Recently, laparoscopic surgery has become standard procedure for either rectal cancer or rectal prolapse. However, the use of laparoscopic low anterior resection
Ryusei Yamamoto   +4 more
doaj   +1 more source

Research on radiotherapy related genes and prognostic target identification of rectal cancer based on multi-omics

open access: yesJournal of Translational Medicine, 2023
Background Radiosensitivity of rectal cancer is related to the radiotherapy efficacy and prognosis of patients with rectal cancer, and the genes and molecular mechanisms related to radiosensitivity of rectal cancer have not been clarified.
Yi Liu   +6 more
doaj   +1 more source

Guía de Práctica Clínica para el manejo del dolor en niños con cáncer [PDF]

open access: yes, 2013
90% de los niños informan de dolor, que a menudo es intenso e infratratado. Muchas personas que sobreviven al cáncer siguen sufriendo dolor después del tratamiento durante el resto de sus vidas (Miaskowski et al., 2004).
Gonzalez-Maria, Esther   +5 more
core   +1 more source

Determination of prognostic factors in early rectal cancer and the implications for rectal preservation surgery [PDF]

open access: yes, 2020
Local excision of early rectal cancer has benefits to patients, with reduced morbidity compared to radical surgery, but carries a higher risk of local recurrence.
Jones, Helen JS
core   +1 more source

Immunological Landscape and Clinical Management of Rectal Cancer

open access: yesFrontiers in Immunology, 2016
The clinical management of rectal cancer and colon cancer differs due to increased local relapses in rectal cancer. However, the current molecular classification does not differentiate rectal cancer and colon cancer as two different entities.
Elísabeth ePérez-Ruiz   +1 more
doaj   +1 more source

Factores genéticos y epigenéticos del cáncer gástrico [PDF]

open access: yes, 2017
El cáncer gástrico (CG) es la primera causa de muerte por cáncer en Colombia, la tumorogénesis gástrica es un proceso gradual y de larga evolución que incluye cambios genéticos y epigenéticos que activan protooncogenes e inactivan genes supresores de ...
Camargo Guerrero, Mauricio   +5 more
core   +1 more source

Metformin is a metabolic modulator and radiosensitiser in rectal cancer

open access: yesFrontiers in Oncology, 2023
Resistance to neoadjuvant chemoradiation therapy, is a major challenge in the management of rectal cancer. Increasing evidence supports a role for altered energy metabolism in the resistance of tumours to anti-cancer therapy, suggesting that targeting ...
Croí E. Buckley   +33 more
doaj   +1 more source

Rectal Microbicides 101 [PDF]

open access: yes, 2010
A fact sheet describing what rectal microbicides are, why they are needed, and the status of research and ...

core   +2 more sources

Manejo del cáncer de recto durante el embarazo

open access: yesRevista Chilena de Obstetricia y Ginecología, 2011
El cáncer de recto tiene baja incidencia en la mujer embarazada, su diagnóstico durante el embarazo suele ser tardío, pues sus síntomas son similares a los propios de la gestación.
Angie Vergara R   +3 more
doaj  

Home - About - Disclaimer - Privacy